Aristotle Capital Management’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$62.6M Sell
1,631,052
-44,408
-3% -$1.71M 0.12% 92
2025
Q1
$64.9M Buy
1,675,460
+74,140
+5% +$2.87M 0.13% 83
2024
Q4
$54.2M Sell
1,601,320
-187,055
-10% -$6.33M 0.1% 99
2024
Q3
$73.1M Sell
1,788,375
-4,428
-0.2% -$181K 0.13% 92
2024
Q2
$69M Buy
1,792,803
+28,341
+2% +$1.09M 0.13% 84
2024
Q1
$75.6M Buy
1,764,462
+187
+0% +$8.02K 0.14% 78
2023
Q4
$65.4M Buy
1,764,275
+31,171
+2% +$1.16M 0.13% 86
2023
Q3
$62.8M Buy
1,733,104
+17,106
+1% +$620K 0.14% 80
2023
Q2
$61.2M Buy
1,715,998
+38,991
+2% +$1.39M 0.12% 91
2023
Q1
$59.7M Buy
1,677,007
+91,975
+6% +$3.27M 0.13% 90
2022
Q4
$55.7M Buy
1,585,032
+177,162
+13% +$6.23M 0.12% 87
2022
Q3
$41.4M Sell
1,407,870
-13,205
-0.9% -$389K 0.09% 102
2022
Q2
$77.3M Buy
1,421,075
+31,255
+2% +$1.7M 0.16% 57
2022
Q1
$75.7M Buy
1,389,820
+59,688
+4% +$3.25M 0.14% 60
2021
Q4
$73.3M Buy
1,330,132
+49,646
+4% +$2.74M 0.12% 68
2021
Q3
$61.2M Buy
1,280,486
+63,613
+5% +$3.04M 0.12% 73
2021
Q2
$60.6M Buy
1,216,873
+240,899
+25% +$12M 0.12% 71
2021
Q1
$43.5M Buy
+975,974
New +$43.5M 0.09% 78
2018
Q2
Sell
-4,999
Closed -$244K 185
2018
Q1
$244K Buy
4,999
+18
+0.4% +$879 ﹤0.01% 170
2017
Q4
$221K Sell
4,981
-26
-0.5% -$1.15K ﹤0.01% 175
2017
Q3
$254K Buy
+5,007
New +$254K ﹤0.01% 140
2015
Q2
Sell
-3,570
Closed -$206K 133
2015
Q1
$206K Sell
3,570
-800
-18% -$46.2K ﹤0.01% 133
2014
Q4
$233K Hold
4,370
﹤0.01% 135
2014
Q3
$251K Hold
4,370
﹤0.01% 133
2014
Q2
$292K Hold
4,370
﹤0.01% 146
2014
Q1
$292K Hold
4,370
﹤0.01% 126
2013
Q4
$292K Hold
4,370
﹤0.01% 126
2013
Q3
$274K Hold
4,370
0.01% 127
2013
Q2
$273K Buy
+4,370
New +$273K 0.01% 123